Professor of Medicine and Adjunct Professor of Epidemiology, Center for Esophageal Diseases and Swallowing
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Evan S. Dellon, MD, MPH, FACG, is a Professor of Medicine and Adjunct Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. Dr. Dellon received his undergraduate degree from Brown University and his medical degree from Johns Hopkins School of Medicine. He completed an internship and residency in Internal Medicine at Massachusetts General Hospital. He performed a clinical and a research fellowship in Adult Gastroenterology at UNC, during which he also received a master's degree in Epidemiology from the UNC School of Public Health. Dr. Dellon is the Director of the Center for Esophageal Diseases and Swallowing, where his clinical focus is on eosinophilic esophagitis (EoE) and eosinophilic GI diseases (EGIDs). Dr. Dellon's main research interest is in the epidemiology, pathogenesis, diagnosis, and treatment of eosinophilic esophagitis and EGIDs. Dr. Dellon has received research funding from the ACG, AGA, CURED Foundation, NIH, the UNC Center for GI Biology and Disease, NC TraCS and the UNC Office of Research, and industry to study EoE and EGIDs.
Disclosure: Consultant: Abbott, Adare, Aimmune, Allakos, Arena, AstraZeneca, Biorasi, Calypso, Celgene/Receptos, Eli Lilly, EsoCap, GlaxoSmithKline, Gossamer Bio, Parexel, Regeneron, Robarts, Salix/Bristol-Myers Squibb, Shire/Takeda
Grant/Research Support: Adare, Allakos, AstraZeneca, Celgene/Receptos, GlaxoSmithKline, Regeneron, Shire/Takeda
Tuesday, October 27, 2020